Kardium is developing a revolutionary medical device for the diagnosis and treatment of atrial fibrillation.
.
.
Location: Canada, British Columbia, Burnaby
Employees: 51-200
Total raised: $249M
Founded date: 2007
Funding Rounds 2
| Date | Series | Amount | Investors |
| 21.06.2024 | - | $104M | - |
| 26.01.2021 | IPO | $145M | - |
Mentions in press and media 9
| Date | Title | Description |
| 21.06.2024 | Kardium's Globe System: A Revolutionary Breakthrough in Atrial Fibrillation Treatment | Kardium Inc., a pioneering medical technology company based in Vancouver, BC, Canada, recently announced a significant milestone in its journey towards transforming the treatment landscape for atrial fibrillation. Securing a substantial $10... |
| 21.06.2024 | Kardium: Atrial Fibrillation Treatment Company Raises $104 Million | Kardium, the developer of the Globe Mapping and Ablation System for the treatment of atrial fibrillation, has raised $104 million in a new financing round. This funding round is led by existing investor Fidelity Management & Research Co... |
| 12.06.2024 | Kardium: $104 Million Raised To Help Treat Atrial Fibrillation | Kardium, the developer of the Globe Mapping and Ablation System for the treatment of atrial fibrillation, announced it has raised $104 million in a new funding round. This funding round is led by existing investor Fidelity Management & ... |
| 12.06.2024 | Kardium Raises $104M in Financing | Kardium Inc., the Vancouver, BC, Canada-based developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, raised US $104m in new financing. The round was led by existing investor Fidelity Management & R... |
| 26.01.2021 | Kardium Raises $115M in Financing | Kardium Inc., a Vancouver, British Columbia, Canada-based developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, raised US $115m in financing. The round was led by Fidelity Management & Research Co... |
| 25.01.2021 | Kardium Announces $115M in New Financing for Innovative Atrial Fibrillation Treatment | Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, has raised US $115 million in a new financing round. The round is led by Fidelity Management & Research Company LLC., together w... |
| 25.01.2021 | BC’s Kardium raises $115 million USD for heart device technology | Kardium, a British Columbia-based medical device company, has secured $115 million USD from Fidelity Management and T. Rowe Price Associates. The round was led by United States-based Fidelity Management, with T. Rowe Price Associates provid... |
| - | Kardium | “Kardium Inc. is a rapidly growing Canadian medical solutions company that has developed the Globe Mapping and Ablation System for the treatment of atrial fibrillation (AF), which affects more than 37 million people worldwide.” |
| - | Bulletin: Kardium raises $115M in new financing | Vancouver-based Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, has raised US $115 million in a new financing round. The round is led by Fidelity Management & Research Company ... |